Novel Applications of Oligo(Carbamoylated Guanidine) in Biofilm Prevention and Treatment

This inventive concept leverages the anti-mycobacterial properties of oligo(carbamoylated guanidine) (OCG) to develop novel solutions for preventing and treating biofilm-related infections in various industries, including medical devices, wound care, agriculture, and marine antifouling coatings.

The original patent disclosed OCGs as potent anti-mycobacterial agents, but their potential in other fields remained unexplored. Biofilm-related infections pose significant challenges in various industries, resulting in device failure, patient morbidity, and crop loss. Current treatments often involve harsh chemicals or antibiotics, which can lead to resistance and environmental concerns. This inventive concept addresses these limitations by adapting OCG technology to combat biofilm-related infections in new applications.

The inventive concept involves the use of OCGs as a key component in various formulations and coatings to prevent biofilm formation and eradicate existing biofilms. In medical devices, OCG-based coatings can reduce the risk of catheter-associated urinary tract infections. In wound care, OCG-infused dressings can promote wound healing by inhibiting bacterial growth and biofilm formation. In agriculture, OCG-based compositions can be applied to crops to prevent disease progression. In marine antifouling coatings, OCGs can prevent biofouling organisms from adhering to underwater surfaces. The OCGs can be tailored to specific applications by modifying their structure, composition, and delivery methods.

The new claims introduce a novel application of OCG technology, expanding its scope beyond anti-mycobacterial treatment to address the unmet needs in biofilm prevention and treatment. The inventive step lies in the recognition of OCGs' potential in these new fields and the development of tailored formulations and coatings to harness their biofilm-inhibiting properties.

Alternative embodiments of the inventive concept could involve the use of OCGs in combination with other antimicrobial agents, the development of OCG-based nanoparticles for targeted delivery, or the incorporation of OCGs into implantable devices. Variations of the coatings and formulations could be designed for specific industries or applications, such as orthopedic implants or dental materials.

The inventive concept has significant commercial potential in various industries, including medical devices, wound care, agriculture, and marine coatings. The market for biofilm prevention and treatment solutions is substantial, with an estimated value of over $10 billion. By adapting OCG technology to these new applications, this inventive concept can provide a competitive edge in these markets and address pressing needs in public health and environmental sustainability.